During the late 1940s, I.G. Farben was “decartelized” by the Allied High Commission led by America’s John J. McCloy—a Philadelphia banker and lawyer with intimate ties to Rockefeller oil and banking interests. Farben stockholders received equal shares of Bayer, Hoechst, and BASF stock.(15,16) Later I.G. Farben progeny included American Home Products, parent to Baxter Corporation—maker of the smallpox vaccine along with the allied European Hoechst-Merck company, Aventis (previously Oravax-Acambis), which also is the sole producer of the West Nile virus vaccine.(17) The West Nile virus, several investigators revealed, sourced from Rockefeller University laboratories that received the germ from Northwest Uganda. There, in central Africa during the late 1930s, virus hunters operating in the vicinity of the Rockefeller pioneered International Agency for Research in Cancer, based in France, initially “isolated” and shipped the germ to America.(1,2)
In fact, American Home Products (AHP) was formed in 1926 but evolved largely under the same direction as Bayer, Hoechst and BASF, that is, from I.G. Farben/Rockefeller financial interests according to cancer investigator and author G. Edward Griffin.(17)
During WWII, Ayerst Laboratories joined AHP and Wyeth International Limited was formed. This company went on to “perfect” the smallpox vaccine according to company promotions.(18) The smallpox vaccine has been credited by many authors and investigators as having greatly contributed to the broad and rapid spread of HIV/AIDS across Africa.(1)
Additionally, The Genetics Institute, an offshoot of the Rockefeller initiated and dominated genetics industry, is a biotech research unit of AHP/Wyeth-Ayerst. The Institute contributes to Baxter’s product line of genetically engineered products, as does AHP, including the smallpox vaccine.(19,20)
Aventis Pharma, with headquarters in Frankfurt, Germany—coincidentally the home of I.G. Farben and the post-war CIA—was formed by Hoechst AG and Rhone-Poulenc S.A. during their merger in 1999. Aventis’s European operations are currently half owned by the Merck pharmaceutical company. (21)
In the United States, the politically powerful Pharmaceutical Research and Manufacturers Association (PhRMA) is directed by Aventis's CEO Richard Markham. Mr. Markham is also Chairman of the Task Force on Emergency Preparedness that has met regularly with Bush administration officials. The Bayer and Merck companies are also heavily represented in PhRMA and its bioterrorism task force.(21) Merck, it should be recalled, was a major recipient of the Nazi “flight capital” that escaped Germany, along with I.G. Farben and Hitler’s chief officers. On August 10, 1944, much of their money was transferred to Merck at the time this company’s president, George W. Merck, was America’s biological weapons industry director.(15) According to Paul Manning, who credited CIA director Allen Dulles for his intelligence and guidance in the book Martin Bormann: Nazi in Exile, the “flight capital scheme” assured the rise of the Fourth Reich. Alternatively called the “Neuordnung” (i.e., New Order) in recently released, previously secret, Farben documents, their plans directed the merger and future growth of the global petrochemical-pharmaceutical and banking cartels. This information was disclosed by Manning and others.(15)